Table 1.
Characteristics | No Hx of COVID-19 (N = 349,676), No. (%) |
Hx of COVID-19 (N = 37,354), No. (%) |
P value |
---|---|---|---|
Age, years | 63 (52, 72) | 61 (49, 70) | <0.001 |
18–29 | 15166 (4.3%) | 1625 (4.4%) | <0.001 |
30–49 | 60828 (17%) | 7734 (21%) | |
50–64 | 111160 (32%) | 12838 (34%) | |
65+ | 162522 (46%) | 15157 (41%) | |
Sex | <0.001 | ||
Female | 190052 (54%) | ‡20952 (≈56%) | |
Race and Ethnicity | <0.001 | ||
Non-Hispanic White | 257334 (74%) | 25833 (69%) | |
Smoking Status | <0.001 | ||
Nonsmoker | 304141 (86%) | 33151 (89%) | |
Charlson Comorbidity Index | <0.001 | ||
0–2 | 178477 (51%) | 17527 (47%) | |
3+ | 171199 (49%) | 19827 (53%) | |
Comorbidities | |||
CKD | 22374 (6.4%) | 3862 (10%) | <0.001 |
CHF | 20816 (6.0%) | 3454 (9.2%) | <0.001 |
COPD | 21089 (6.0%) | 3134 (8.4%) | <0.001 |
Coronary Artery Disease | 39221 (11%) | 5852 (16%) | <0.001 |
Depression | 35956 (10%) | 5875 (16%) | <0.001 |
Diabetes | 41584 (12%) | 7144 (19%) | <0.001 |
GERD | 58830 (17%) | 9432 (25%) | <0.001 |
Hypertension | 100981 (29%) | 14669 (39%) | <0.001 |
Liver Disease | 5730 (1.6%) | 977 (2.6%) | <0.001 |
Obesity | 51446 (15%) | 8920 (24%) | <0.001 |
Relative Risk of Surgery | 0.058 | ||
Low Risk | 134385 (38%) | 14364 (38%) | |
Medium Risk | 166702 (48%) | 17642 (47%) | |
High Risk | 48589 (14%) | 5348 (14%) | |
Vaccine Status | <0.001 | ||
Fully Vaccinated | 48441 (14%) | 5381 (14%) | |
Non-Fully Vaccinated | 301235 (86%) | 31973 (86%) | |
Pandemic Era | <0.001 | ||
Alpha | 204624 (59%) | 9661 (26%) | |
Delta | 61838 (18%) | 5942 (16%) | |
Omicron | 83214 (24%) | 21751 (58%) |
To comply with N3C policy, counts below 20 are displayed as <20 and additional values were skewed by up to 5 in order to render it impossible to back-calculate precise counts in the ‘Missing or Unknown’ category. Hx: history; CKD: chronic kidney disease; CHF: congestive heart failure; COPD: chronic obstructive pulmonary disease; GERD: gastroesophageal reflux disease.